You are currently viewing a new version of our website. To view the old version click .

Inflammatory Bowel Disease’s Journey: From Metabolism and Immunity to New Therapeutic Horizons

This special issue belongs to the section “Molecular Pathology, Diagnostics, and Therapeutics“.

Special Issue Information

Dear Colleagues,

Inflammatory bowel diseases (IBD) encompassing two major forms, Crohn's disease (CD) and ulcerative colitis (UC), are immune-mediated disorders with a complex genetic background and involve constantly changing endogenous and environmental factors.

The comprehension of molecular actors, and the implementation of multi-omics technologies, as well as the pivotal role of the gut microbiome, are compelling the research community to reevaluate the knowledge and molecular processes. As our comprehension of the pathogenic mechanisms of inflammatory bowel disease (IBD) increases, the therapeutic armamentarium for its treatment can expand, and novel target therapies join the treatment pipeline.

In the present Research Topic, we encourage experienced colleagues to submit original research articles, case studies, and review articles regarding molecular and/or metabolic features in order to identify novel biomarkers, and novel diagnostic tools for detection and monitoring, to improve the medical treatment of UC and CD, to manage concomitant extra-intestinal manifestations and to identify novel therapeutics approaches.

Dr. Rocco Spagnuolo
Dr. Daniela Pugliese
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • intestinal barrier function
  • gut microbiota
  • inflammation
  • bacterial metabolites
  • immunological pathways
  • biomarkers and predictors
  • nutrients
  • cytokines

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Int. J. Mol. Sci. - ISSN 1422-0067